David Wainson

David Wainson

Life Sciences Expert
David Wainson has a background in science and explores the intersection of biology and healthcare. He is a thought leader in bioethics, genomics, and personalized medicine. David unpacks complex topics in an accessible manner, utilizing case studies and clinical trials as real-world examples of how biology supports advanced patient care.
How Will Medicaid Cuts Impact Disability Care in America?
Care How Will Medicaid Cuts Impact Disability Care in America?

Understanding the Growing Crisis in Disability Support Systems The fundamental promise of the American social safety net is currently facing an unprecedented challenge that threatens to dismantle the very foundations of independent living for millions of citizens with significant physical and

Will Candid and Rallybio Redefine Autoimmune Care?
Care Will Candid and Rallybio Redefine Autoimmune Care?

The high-stakes landscape of biotechnology is currently undergoing a seismic transformation as the merger between Candid Therapeutics and Rallybio signals a departure from traditional drug development strategies. This orchestration involves a high-stakes reverse merger that places Candid at the

Louisiana Seeks to End Telehealth Access for Mifepristone
Care Louisiana Seeks to End Telehealth Access for Mifepristone

The intersection of digital healthcare innovation and judicial oversight has reached a critical juncture that could redefine how millions of Americans access essential reproductive medications. As the landscape of reproductive healthcare continues to shift, medication abortion has emerged as the

How To Build A Healthcare Platform That Actually Scales
Editorial How To Build A Healthcare Platform That Actually Scales

The app era in healthcare is fading. Point solutions hit a ceiling the moment care moves beyond a single workflow, department, or reimbursement rule. What health systems, payers, and innovators need now is a shared foundation that multiple products, users, and partners can build on together. A

Gilead to Acquire Arcellx for $7.8 Billion to Boost Cell Therapy
Care Gilead to Acquire Arcellx for $7.8 Billion to Boost Cell Therapy

Faisal Zain is a distinguished authority in medical technology and biopharmaceutical manufacturing, known for his deep expertise in the logistical and technical hurdles of cell-based treatments. As a strategist who has seen the evolution of diagnostics and therapeutics from the laboratory bench to

Review of BridgeBio Infigratinib
Care Review of BridgeBio Infigratinib

Introduction: Assessing a New Oral Therapy for Achondroplasia For families navigating the complexities of achondroplasia, the prospect of replacing daily or weekly injections with a simple pill represents a profound shift in the treatment paradigm. This review evaluates the potential of

Sleep Is a Missing Piece in Mental Health Care
Care Sleep Is a Missing Piece in Mental Health Care

We are joined by Dr. Lauren Waterman, a consultant psychiatrist specializing in the intricate science of insomnia. In our conversation, we will explore the often-misunderstood differences between insomnia and sleep deprivation, the psychological traps that turn normal nighttime awakenings into

Study Reveals What Dignity in Care Means to Patients
Care Study Reveals What Dignity in Care Means to Patients

The sterile scent of antiseptic and the rhythmic beeping of monitors often define the hospital experience, but for patients, the true measure of care lies in something far less tangible than clinical procedures. A groundbreaking study into the lived experiences of hospitalized individuals confirms

Could a New Eye Drop Make Reading Glasses Obsolete?
Care Could a New Eye Drop Make Reading Glasses Obsolete?

The Dawn of a New Era in Vision Correction For millions of adults, the simple act of reading a menu, a text message, or a book eventually becomes a challenge. This creeping blurriness, known as presbyopia, has long been an accepted, if inconvenient, part of aging, sending a steady stream of people

AI and the Path to Better Patient Care
Editorial AI and the Path to Better Patient Care

According to estimates referenced by public health experts at the Harvard School of Public Health , artificial intelligence in healthcare could improve health outcomes by around 40 % and reduce treatment costs by up to 50 %. These numbers underscore the technology’s potential to enhance care q

Loading
Latest Articles

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later